| MolName | (2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[[4-(2-morpholin-4-yl-2-oxoethoxy)phenyl]methyl]pentanamide |
| MolecularFormula | C45H51N3O7 |
| Smiles | O[C@@H](C[C@@H](Cc(cc1)ccc1OCC(N1CCOCC1)=O)C(N[C@H]([C@@H](C1)O)c2c1cccc2)=O)CN([C@@H](Cc1ccccc1)C[C@@H]1Cc2ccccc2)C1=O |
| InChI | InChI=1S/C45H51N3O7/c49-38(29-48-37(25-32-11-5-2-6-12-32)26-36(45(48)53)24-31-9-3-1-4-10-31)27-35(44(52)46-43-40-14-8-7-13-34(40)28-41(43)50)23-33-15-17-39(18-16-33)55-30-42(51)47-19-21-54-22-20-47/h1-18,35-38,41,43,49-50H,19-30H2,(H,46,52)/t35-,36+,37-,3 |
| InChIK | IDBLGZUZWCEMCW-NTYKNBAASA-N |
| TotalMolweight | 745.914 |
| Molweight | 745.914 |
| MonoisotopicMass | 745.372702 |
| CLogP | 5.1536 |
| CLogS | -5.56 |
| H Acceptors | 10 |
| H Donors | 3 |
| TotalSurfaceArea | 570.17 |
| Relative PSA | 0.18219 |
| PolarSurfaceArea | 128.64 |
| Druglikeness | 5.4246 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.43636 |
| Fragments | 1 |
| Non HAtoms | 55 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 6 |
| Rotatable Bond | 15 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 22 |
| Symmetricatoms | 8 |
| Amides | 3 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[[4-(2-morpholin-4-yl-2-oxoethoxy)phenyl]methyl]pentanamide | 2 - (2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[[4-(2-morpholin-4-yl-2-oxoethoxy)phenyl]methyl]pentanamide